{
    "2021-11-04": [
        [
            {
                "time": "",
                "original_text": "康泰生物疫苗获印尼紧急使用 业内：海外同样存在竞争，新冠疫苗增长期或已过去",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "疫苗",
                        "印尼",
                        "紧急使用",
                        "海外竞争",
                        "新冠疫苗",
                        "增长期"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "康泰生物重组腺病毒载体新冠疫苗在印尼获批紧急使用",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "重组腺病毒载体",
                        "新冠疫苗",
                        "印尼",
                        "获批",
                        "紧急使用"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}